ProtoKinetix, Inc.

0.0055+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · PKTX · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
2.14M
P/E (TTM)
-
Basic EPS (TTM)
0.00
Dividend Yield
0%

Recent Filings

About

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

CEO
Mr. Clarence Edward Smith
IPO
4/22/2002
Sector
Healthcare
Industry
Biotechnology